Skip to main content

FibroBiologics Announces Pricing of $3 Million Public Offering

HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the pricing of a best efforts public offering of an aggregate of 2,272,728 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,272,728 shares of common stock (the “Warrants”), at a combined public offering price of $1.32 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $1.32 per share and will be exercisable beginning on the effective date of stockholder...

Continue reading

Purpose Investments Inc. Announces 2026 First Quarter Distributions for Purpose Specialty Lending Trust

TORONTO, March 31, 2026 (GLOBE NEWSWIRE) — Purpose Investments Inc. is pleased to announce the 2026 first-quarter distributions for Purpose Specialty Lending Trust.  Ticker Symbol/FundServ Distributionper share/unit Ex Distribution Date Record Date Payable DatePurpose Specialty Lending Trust – Class A Unlisted $0.3736 03/31/2026 03/31/2026 04/22/2026Purpose Specialty Lending Trust – Class F Unlisted $0.3861 03/31/2026 03/31/2026 04/22/2026Purpose Specialty Lending Trust – Class U Unlisted US$ 0.3497 03/31/2026 03/31/2026 04/22/2026Purpose Specialty Lending Trust – Class A1,Series 2 Unlisted $0.4319 03/31/2026 03/31/2026 04/22/2026Purpose Specialty Lending Trust – Class F, Series3 Unlisted $0.4471 03/31/2026 03/31/2026 04/22/2026Purpose Specialty Lending Trust – Class 1 Units (Series A-1) PFC3400 $0.4363 n/a 03/30/2026 03/31/2026Purpose...

Continue reading

Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly

Lilly to gain ownership of Centessa’s OX2R agonist pipeline designed to improve outcomes across sleep-wake disorders Centessa’s OX2R agonist pipeline was jointly discovered by Nxera and Centessa, and Nxera retains a material economic interest in its future development and commercializationTokyo, Japan and Cambridge, UK, 1 April 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner, Centessa Pharmaceuticals Limited (“Centessa”), has announced that it entered into a definitive agreement regarding its acquisition by Eli Lilly and Company (“Lilly”) on 31 March 2026 (US local time). Please refer to the full text of Centessa’s news release at the link below:https://investors.centessa.com/press-releases/  Centessa’s orexin receptor 2 (OX2R) agonist series, cleminorexton (formerly ORX750),...

Continue reading

Clip Money Inc. Reports 2025 Year End Results

TORONTO, March 31, 2026 (GLOBE NEWSWIRE) — Clip Money Inc. (TSX-V: CLIP) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the fiscal year ended December 31, 2025. The Company reported record revenue growth in 2025, up 143% from 2024. During the same period, the Company’s Cost of Revenues only increased 52%, demonstrating strong operating leverage that is expected to continue in 2026. All dollar amounts referenced herein are in U.S. dollars. 2025 Financial HighlightsRevenue for 2025 was $5,743,688, compared to $2,360,309 in 2024, representing 143% growth year-over-year (“YoY”). This growth was fueled by a 129% increase in average new deposit users and a 5% increase in revenue per user, driven by revenue from new products....

Continue reading

Cavvy Energy Announces Exercise of Warrants

Not For Distribution to United States News Wire Services or Dissemination in United States CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) — Cavvy Energy Ltd. (“Cavvy” or the “Company”) (TSX:CVVY) announces the cashless exercise of common share purchase warrants (the “Warrants”) by PCEP Canadian Holdco, LLC. (“PCEP”). The Warrants were issued to PCEP in 2023 and 2024 in connection with debt financing to Cavvy, then Pieridae Energy Limited. The Warrants, totalling 19,804,414, have been exercised using the cashless exercise mechanism specified in the warrant certificates. The warrants were exercised at a weighted average price of $0.4485 per share, in exchange for the issuance of 13,030,536 common shares. The Company has 309,080,041 common shares and nil share purchase warrants outstanding, following the exercise of the Warrants. ABOUT...

Continue reading

Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) — Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that it intends to change its corporate name from “Algernon Health Inc.” to “Grey Matters Health Inc.” (the “Name Change”). The Company has reserved the new name and new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new symbols for the OTCQB and Frankfurt exchange will be provided shortly. Grey Matter is a biological term defined as the darker tissue of the brain and spinal cord, consisting mainly of nerve cell bodies and branching dendrites. The addition of an “s” to the name is a play on words underscoring the importance of cognitive health, and the Company’s interest in brain related healthcare programming. Principally,...

Continue reading

Prairie Provident Resources Announces Fourth Quarter and Year-End 2025 Financial and Operating Results and 2025 Year End Reserves

CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident” or the “Company”) (TSX:PPR) announces its financial and operating results for the fourth quarter and year ended December 31, 2025, along with its year-end reserves. Prairie Provident’s audited annual consolidated financial statements and related Management’s Discussion and Analysis (“MD&A”) for the year ended December 31, 2025, and Annual Information Form dated March 31, 2026 containing year-end reserves data and other information for the period, are available on the Company’s website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca. 2025 REVIEW AND UPDATEPrairie Provident drilled six wells, five in Michichi and one in its Princess area. Four of the wells are...

Continue reading

Precision Drilling Corporation 2026 First Quarter Results Conference Call and Webcast

CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) — Precision Drilling Corporation (Precision) intends to release its 2026 first quarter results after the market closes on Wednesday, April 29, 2026, and has scheduled a conference call to begin at 11:00 a.m. MT (1:00 p.m. ET) on the next day, Thursday, April 30, 2026. To participate in the conference call please register at the URL link below. Once registered, you will receive a dial-in number and a unique PIN, which will allow you to ask questions. https://register-conf.media-server.com/register/BI8811660f92894f7aa14eca5d58cbc0df The call will also be webcast and can be accessed through the link below. A replay of the webcast call will be available on Precision’s website for 12 months. https://edge.media-server.com/mmc/p/952icqoy About Precision Precision is a leading provider of...

Continue reading

Terrata Homes Debuts in Orlando Market with Grand Opening of Saddle Hill in Fruitland Park

The Mantle plan at Saddle Hill features four bedrooms, three bathrooms and a media room.Terrata Homes opens first Orlando area community in Fruitland Park, FL.ORLANDO, Fla., March 31, 2026 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is proud to introduce its luxury brand, Terrata Homes, to the Orlando, Florida market with the grand opening of Saddle Hill. As Terrata Homes’ first neighborhood in the region, Saddle Hill sets a new benchmark for elevated living by combining upscale design and expansive, half-acre homesites. Saddle Hill introduces a collection of spacious, single-family homes designed to deliver both luxury and functionality. Homes range from 2,115 square feet to 3,389 square feet with four bedrooms and two to three bathrooms, featuring single-story, open-concept layouts and flexible living spaces. A...

Continue reading

Western Forest Products Inc. Announces Release Date of First Quarter 2026 Results and Conference Call Details

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) — Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) first quarter 2026 financial and operating results will be released on Wednesday, May 6, 2026. Western will host its first quarter 2026 analyst conference call on Thursday, May 7, 2026 at 12:00 p.m. PDT (3:00 p.m. EDT). Steven Hofer, President and Chief Executive Officer, Glen Nontell, Chief Financial Officer and Bruce Alexander, Senior Vice President, Sales, Marketing and Manufacturing, will discuss the Company’s first quarter 2026 results followed by a question and answer session with the analyst community. To join the conference call, dial:Toll-free from Canada and the US: 1-877-883-0383International: 1-647-846-2809Passcode: 6651876# To access the instant replay of the call, dial:Toll-free from Canada...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.